![Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical](https://cdn.i.haymarketmedia.asia/?n=campaign-asia%2fcontent%2f39082_story_images.jpg&h=570&w=855&q=100&v=20170226&c=1)
According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.
OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.
Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.